← Leaderboards
Qin Cheng
Queensland Institute Of Medical Research
$981,790
Attributed
$1,160,209
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $189K · FY2005–13$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,160,209 · 2
By mechanism
R01$803,371 · 1
R21$356,838 · 1
Top collaborators
- John Adams2 shared
Others in their field
Top investigators on “Plasmodium Falciparum”
- Stephen Lev Hoffman · Sanaria, Inc.$74,168,946
- Wilhelmus G. J. Hol · University Of Washington$26,680,349
- David Armand Fidock · Columbia University Health Sciences$25,621,906
- Manoj T Duraisingh · Harvard University D/B/A Harvard School Of Public Health$24,979,796
- Pradipsinh K. Rathod · Catholic University Of America$22,994,754
- Stefan H.i. Kappe · Seattle Children'S Hospital$22,158,820
Research focus
Plasmodium FalciparumDrug ResistanceMalariaClinical ResearchLaboratory MouseChloroquineAntimalarial AgentsHuman SubjectComputer SimulationSurface AntigensHost Organism InteractionMicroorganism AntigenNucleic Acid SequenceImmune Tolerance /UnresponsivenessGeographic SiteHuman Therapy EvaluationCombination ChemotherapyAtovaquoneAntigen Antibody ReactionEpidemiologyClearance RateAlternatives To Animals In ResearchDisease /Disorder ModelHumoral Immunity
Grant awards (7)
Genetic screen for P. vivax CQR$180,146
R21 · FY2013 · AI
Genetic screen for P. vivax CQR$176,692
R21 · FY2012 · AI
Antigenic Variation and Drug Resistance In P. falciparum$184,559
R01 · FY2006 · AI · contact PI
Antigenic Variation and Drug Resistance In P. falciparum$189,000
R01 · FY2005 · AI
Antigenic Variation and Drug Resistance In P. falciparum$159,000
R01 · FY2004 · AI
EVOLUTION OF DRUG RESISTANCE IN PLASMODIUM FALCIPARUM$137,328
R01 · FY2001 · AI
EVOLUTION OF DRUG RESISTANCE IN PLASMODIUM FALCIPARUM$133,484
R01 · FY2000 · AI